Visit the Vivaldi Biosciences Page. Visit the Management Team Page. Visit the Board of Directors Page. Visit the Scientific Advisors Page.
 

 



ELLIOTT KIEFF, MD, PhD

 

ELLIOTT KIEFF, MD, PhD

Dr. Kieff is a co-founder of Vivaldi Biosciences and a Scientific Advisor to the company. He is the Harriet Ryan Albee Professor of Medicine, Professor of Microbiology and Immunology, and Director of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School. Dr. Kieff chaired the Virology Program at Harvard from 1992 to 2005. Previously, he was the Block Professor of Medicine and Microbiology and Director of Infectious Diseases at the University of Chicago. Dr. Kieff is internationally recognized for landmark discoveries in elucidating the molecular pathogenesis of Epstein-Barr virus (EBV) infection and associated cancers, and his work has resulted in vaccines and immunotherapeutics. Dr. Kieff identified and cloned the EBV genes expressed during latency and immortalization of B lymphocytes and elucidated their function in immortalizing cells. He also discovered the mechanisms by which a viral protein, LMP1, transforms lymphocytes by affecting the signaling pathway from the tumor necrosis factor receptor protein. Dr. Kieff has published more than 230 research papers and holds eleven patents. He completed his undergraduate degree at the University of Pennsylvania, and earned his MD at Johns Hopkins University. He was an Intern, Resident, and PhD student at the University of Chicago. Dr. Kieff serves of the editorial board of the Journal of Virology. He is a Member of the American Academy of Arts and Sciences, the Institute of Medicine of the National Academy of Sciences, and the National Academy of Sciences.

 

   
 


Website Design and website updates by LoneTree Web Studio, Brentwood, CA

Home | About | Management Team | Board of Directors | Scientific Advisors | Product Development | Publications | Contact